Michael Child
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Pharmacological Effects and Toxicity Studies, Pneumocystis jirovecii pneumonia detection and treatment, HIV/AIDS Research and Interventions
Most-Cited Works
- → Effect of Rifampin on Steady-State Pharmacokinetics of Atazanavir with Ritonavir in Healthy Volunteers(2006)79 cited
- → Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir(2009)78 cited
- → LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy(1995)76 cited
- → Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women(2011)63 cited
- → Effect of Concomitantly Administered Rifampin on the Pharmacokinetics and Safety of Atazanavir Administered Twice Daily(2007)56 cited
- → Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction(2005)47 cited
- → The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor(2014)30 cited
- → Infrared studies of the adsorption of triethylamine on silica at the solid/vapor and solid/liquid interfaces(1982)28 cited
- → Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study(2011)18 cited
- → Effects of the H 2 -Receptor Antagonist Famotidine on the Pharmacokinetics of Atazanavir-Ritonavir With or Without Tenofovir in HIV-Infected Patients(2011)18 cited